HU207439B - Method for producing micro-capsuled medicine preparations - Google Patents

Method for producing micro-capsuled medicine preparations Download PDF

Info

Publication number
HU207439B
HU207439B HU874335A HU433587A HU207439B HU 207439 B HU207439 B HU 207439B HU 874335 A HU874335 A HU 874335A HU 433587 A HU433587 A HU 433587A HU 207439 B HU207439 B HU 207439B
Authority
HU
Hungary
Prior art keywords
insulin
active ingredient
stable
proteinaceous
microspheres
Prior art date
Application number
HU874335A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT52947A (en
Inventor
Solomon S Steiner
Robert Rosen
Original Assignee
Emisphere Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emisphere Tech Inc filed Critical Emisphere Tech Inc
Publication of HUT52947A publication Critical patent/HUT52947A/hu
Publication of HU207439B publication Critical patent/HU207439B/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/559Redox delivery systems, e.g. dihydropyridine pyridinium salt redox systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU874335A 1986-08-18 1987-08-14 Method for producing micro-capsuled medicine preparations HU207439B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89736186A 1986-08-18 1986-08-18

Publications (2)

Publication Number Publication Date
HUT52947A HUT52947A (en) 1990-09-28
HU207439B true HU207439B (en) 1993-04-28

Family

ID=25407824

Family Applications (1)

Application Number Title Priority Date Filing Date
HU874335A HU207439B (en) 1986-08-18 1987-08-14 Method for producing micro-capsuled medicine preparations

Country Status (5)

Country Link
KR (1) KR950009089B1 (ko)
CN (1) CN1034858A (ko)
DK (1) DK205988A (ko)
FI (1) FI102456B1 (ko)
HU (1) HU207439B (ko)

Also Published As

Publication number Publication date
FI102456B (fi) 1998-12-15
CN1034858A (zh) 1989-08-23
HUT52947A (en) 1990-09-28
FI890782A (fi) 1989-02-17
DK205988D0 (da) 1988-04-15
FI102456B1 (fi) 1998-12-15
DK205988A (da) 1988-05-31
KR880701601A (ko) 1988-11-04
FI890782A0 (fi) 1989-02-17
KR950009089B1 (ko) 1995-08-14

Similar Documents

Publication Publication Date Title
US4925673A (en) Delivery systems for pharmacological agents encapsulated with proteinoids
USRE35862E (en) Delivery systems for pharmacological agents encapsulated with proteinoids
US4983402A (en) Orally administerable ANF
US4976968A (en) Anhydrous delivery systems for pharmacological agents
Ramadas et al. Lipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats
US4855134A (en) Sustained-release preparation
FI97691C (fi) Menetelmä lääkkeenvälityskoostumuksen valmistamiseksi
AU680408B2 (en) Self-assembling diketopiperazine drug delivery system
US5679377A (en) Protein microspheres and methods of using them
US5902606A (en) Solid and liquid solutions of sparingly water-soluble medicinal substances
US6645525B1 (en) Ionically formulated biomolecule microcarriers
US7976847B2 (en) Controlled release CGRP delivery composition for cardiovascular and renal indications
JPH07508004A (ja) プロテイノイド担体並びにその製造方法および使用方法
JPH04503508A (ja) 薬物送達組成物
JPH0780782B2 (ja) 貯蔵安定で認容性のエリトロポエチン製剤及びその製法
WO1995022318A1 (en) Drugs, vaccines and hormones in polylactide coated microspheres
EP0140255A2 (en) Sustained-release injections
JPH0150686B2 (ko)
EP0138216A2 (en) Sustained-release IFN preparation for parenteral administration
JP2802488B2 (ja) 経鼻吸収用生理活性ペプチド組成物
IL104093A (en) Prolamine is expected to mask the taste of drugs given orally
HU207439B (en) Method for producing micro-capsuled medicine preparations
DE3745075C2 (de) Mikroverkapselung für pharmakologische Mittel
JP2010514679A (ja) 制御放出組成物及び方法
PT86571B (pt) Metodo para a microencapsulacao de agentes farmacologicos e processo para a preparacao de composicoes farmaceuticas que contem esses agentes

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee